In the present study, we investigated the effect of fluoropyrimidines on the growth of Ureaplasma urealyticum. Addition of fluoropyrimidines strongly inhibited bacterial growth. Growth inhibition by these analogues could be reversed by addition of either thymidine or deoxyuridine, suggesting inhibition of thymidylate biosynthesis as the mechanism in operation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1081/NCN-200027714 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.
Oncologist
December 2024
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 484-8681, Japan.
Purpose: Human epidermal growth factor receptor 2 (HER2) status is a critical biomarker in advanced gastric cancer (AGC). While the role of HER2-positive tumors in guiding targeted therapies is well-established, the clinical implications of HER2-low expression, defined as immunohistochemistry (IHC) 1+ or IHC 2+/in situ hybridization-negative (ISH-negative), remain undetermined. The aim of this study was to investigate the prognostic significance and clinicopathological features of HER2-low AGC.
View Article and Find Full Text PDFClinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer.
ESMO Open
December 2024
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; Department of Interdisciplinary Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Electronic address:
Background: This study aimed to investigate the prevalence of claudin 18.2 (CLDN18.2) positivity, with a particular focus on intratumoral heterogeneity, and its association with clinicopathological features in metastatic or unresectable gastric cancer (GC).
View Article and Find Full Text PDFMaintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial.
ESMO Open
December 2024
Department of Medical Oncology IMIBIC, Universidad de Córdoba, CIBERONC, Instituto de Salud Carlos III, Hospital Universitario Reina Sofía, Córdoba, Spain.
Background: The combination chemotherapy i.v. 5-fluorouracil (5-FU), irinotecan, and aflibercept (FOLFIRI-A) is a standard second-line treatment of metastatic colorectal cancer (mCRC).
View Article and Find Full Text PDFSingle nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer.
Future Sci OA
December 2024
Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
Article Synopsis
- The study examines how single-nucleotide polymorphisms (SNPs) in enzyme-coding genes impact the effectiveness and side effects of chemotherapy in colorectal cancer patients receiving fluoropyrimidine-based treatments.!* -
- It involved analyzing enzyme activity to find correlations with treatment outcomes, drug toxicity, and hypersensitivity reactions in 51 patients.!* -
- The findings suggest that pharmacogenetics can be used as a predictive tool in oncology, aiding in understanding how patients respond to chemotherapy and their potential for experiencing side effects.!*
Doxifluridine effectively kills antibiotic-resistant in chronic obstructive pulmonary disease.
Microbiol Spectr
November 2024
Department of Respiratory, The Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally, often exacerbated by infections such as methicillin-resistant (MRSA). The rise in antibiotic-resistant strains complicates treatment and underscores the need for novel therapeutic drugs. In this paper, we further investigated the antimicrobial potential of a fluoropyrimidine anticancer drug doxifluridine against multidrug-resistant .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!